RELIEF THERAPEUTICS HOLDING/ CH1251125998 /
| 11/15/2024 4:42:32 PM | Chg. -1.42 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 6.02CHF | -19.09% | 491 Turnover: 2,955.82 |
-Bid Size: - | -Ask Size: - | 85.65 mill.CHF | - | - |
Assets
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 0.0000 | 0.0000 | .0400 | 2.6910 | 2.9670 | ||||||
| Intangible Assets | 19.6000 | 30.8000 | 192.3000 | 162.9150 | 54.4140 | ||||||
| Long-Term Investments | 0.0000 | .4000 | 0.0000 | - | - | ||||||
| Fixed Assets | 19.6000 | 31.2000 | 196.6000 | 166.2150 | 58.0860 | ||||||
| Inventories | 0.0000 | 0.0000 | .4000 | .2270 | .5570 | ||||||
| Accounts Receivable | 0.0000 | 0.0000 | 1.3000 | 1.3210 | 1.1710 | ||||||
| Cash and Cash Equivalents | .2000 | 38.1000 | 44.8000 | 19.2370 | 14.5560 | ||||||
| Current Assets | .3000 | 46.9000 | 55 | 22.5830 | 18.3040 | ||||||
| Total Assets | 19.9000 | 78 | 251.6000 | 188.7980 | 76.3900 | ||||||
Liabilities
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | .3000 | 1.4000 | 1.7000 | 1.6250 | 1.0250 | ||||||
| Long-term debt | - | - | .4000 | 2.2480 | .0090 | ||||||
| Liabilities to Banks | 0.0000 | .9000 | 1.7000 | - | - | ||||||
| Provisions | 2.7000 | 4.3000 | 57.1000 | 31.7390 | 6.2030 | ||||||
| Liabilities | 4.5000 | 11 | 70.1000 | 43.3810 | 24.1620 | ||||||
| Share Capital | 21.1000 | 32.5000 | 44.1000 | - | - | ||||||
| Total Equity | 14.3000 | 67 | 181.5000 | 145.4170 | 52.2280 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Total liabilities equity | 19.9000 | 78 | 251.6000 | 188.7980 | 76.3900 | ||||||
Income Statement
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 0.0000 | 0.0000 | 3.3000 | 16 | 6.0330 | ||||||
| Depreciation (total) | - | - | - | 30.2840 | - | ||||||
| Operating Result | -12.1000 | -9.1000 | -34.3000 | -52.0400 | -110.8280 | ||||||
| Interest Income | - | - | - | -2.2760 | -.8560 | ||||||
| Income Before Taxes | -12.2000 | -6.3000 | -35.5000 | - | - | ||||||
| Income Taxes | 4.7000 | -1.5000 | .8000 | 3.5260 | -13.5030 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -7.5000 | -7.8000 | -34.3000 | -50.7900 | -98.1810 | ||||||
Per Share
Cash Flow
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -.7000 | -18.3000 | -35.7000 | -24.1260 | -17.6120 | ||||||
| Cash Flow from Investing Activities | 0.0000 | 3 | -30.3000 | -7.9990 | 8.6950 | ||||||
| Cash Flow from Financing | .6000 | 58.2000 | 67.7000 | 6.4170 | 4.0500 | ||||||
| Decrease / Increase in Cash | -.1000 | 43 | 1.7000 | - | - | ||||||
| Employees | - | - | - | - | - | ||||||
